Back to search

Article

The role of histone deacetylase 4 (HDAC4) in acquired cisplatin-resistant ovarian cancer

2011-01-01

Abstract excerpt

Resistance to platinum is a major problem in the treatment of ovarian cancer. Molecular profiling of isogenic ovarian cancer cell line pairs derived from tumour cells pre- and post- clinical resistance, identified that histone deacetylase 4 (HDAC4) is over-expressed in cisplatin-resistant cells relative to sensitive derivatives. HDAC4 siRNA and HDACi treatment resensitised resistant cells to cisplatin. Furthermore...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5c42924c-f62d-5d48-b154-5cc82b3b2acd
DOI
10.25560/9068
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The role of histone deacetylase 4 (HDAC4) in acquired cisplatin-resistant ovarian cancerDOI 10.25560/9068
Select a neighboring publication to make it the new centre.